← Leaderboards
Miao Zhang
Chapman University
$1,263,758
Attributed
$2,093,492
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,816,632 · 5
By mechanism
R33$1,446,280 · 2
R01$580,619 · 1
R15$434,024 · 1
R21$355,709 · 1
Top collaborators
- Ilya B Bezprozvanny4 shared
- Heike Wulff1 shared
Others in their field
Other Emerging Leaders on “Mutant”
- Timothy M Willson · University Of Cape Town$12,760,250
- Jacqueline K White · Jackson Laboratory$12,159,072
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$9,169,050
- Kristen A Johnson · California Institute/Biomedical Research$8,530,970
- Frederic Geissmann · Sloan-Kettering Inst Can Research$7,125,954
- John Damon Chodera · Sloan-Kettering Inst Can Research$6,599,276
Research focus
MutantAffectClinical DevelopmentPreclinical DevelopmentVirtualComplexCerebellar AtaxiaElectrophysiology (Science)NeuronsPositive Allosteric ModulatorPurkinje CellsStructureDrug TargetingPlayFutureNervous System DisorderProteinsHigh Throughput ScreeningBindingAtaxiaBiophysical TechniquesDominant Genetic ConditionsCrystallizationBiological Process
Grant awards (6)
Molecular mechanism for pharmacological activation of KCa2 channels$580,619
R01 · FY2025 · NS · contact PI
Channelopathy of KCa2.3 and Zimmermann-Laband syndrome$434,024
R15 · FY2024 · NS · contact PI
Development of SK channel modulators as therapeutic agents for ataxia$723,140
R33 · FY2021 · NS · contact PI
ConProject-001$723,140
R33 · FY2021 · NS · contact PI
Development of SK channel modulators as therapeutic agents for ataxia$168,959
R21 · FY2019 · NS · contact PI
Development of SK channel modulators as therapeutic agents for ataxia$186,750
R21 · FY2018 · NS · contact PI